应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KAPA Kairos Pharma, Ltd.
圣诞节休市 12-24 13:00:00 EST
1.70
-0.01
-0.87%
盘后
1.70
+0.00
0.00%
15:43 EST
最高
1.77
最低
1.66
成交量
1.63万
今开
1.77
昨收
1.72
日振幅
6.45%
总市值
2,184万
流通市值
676.51万
总股本
1,285万
成交额
2.79万
换手率
0.41%
流通股本
397.95万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Calidi Biotherapeutics, Inc.盘中异动 股价大涨18.53%
市场透视 · 11-13
Calidi Biotherapeutics, Inc.盘中异动 股价大涨18.53%
Kairos Pharma(KAPA)盘前涨逾9% 拟与临床实验室合作开发配套生物标记物
金吾财讯 · 09-25
Kairos Pharma(KAPA)盘前涨逾9% 拟与临床实验室合作开发配套生物标记物
Kairos Pharma盘前涨6% 公司计划与临床实验室合作
新浪财经 · 09-25
Kairos Pharma盘前涨6% 公司计划与临床实验室合作
公司概况
公司名称:
Kairos Pharma, Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Kairos Pharma, Ltd.于2013年6月17日根据加利福尼亚州法律注册成立,名称为NanoGB13, Inc.,随后于2023年5月10日转换为特拉华州公司,名称为Kairos Pharma, Ltd.。该公司是一家临床阶段的生物制药公司,致力于为癌症患者提供治疗,旨在克服免疫抑制和耐药性方面的关键障碍。这些疗法包括用于治疗前列腺癌、肺癌、乳腺癌和胶质母细胞瘤的抗体和小分子。
发行价格:
--
{"stockData":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":1.7,"timestamp":1735063200000,"preClose":1.715,"halted":0,"volume":16315,"hourTrading":{"tag":"盘后","latestPrice":1.7,"preClose":1.7,"latestTime":"15:43 EST","volume":22,"amount":37.76,"timestamp":1735073022261},"delay":0,"floatShares":3979486,"shares":12846785,"eps":-0.257574,"marketStatus":"圣诞节休市","marketStatusCode":7,"change":-0.015,"latestTime":"12-24 13:00:00 EST","open":1.77,"high":1.7706,"low":1.66,"amount":27882.853817,"amplitude":0.06449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.257574,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735203600000},"adr":0,"listingDate":1717992000000,"adjPreClose":1.715,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.715,"latestTime":"08:03 EST","volume":10,"amount":18,"timestamp":1735045381187},"postHourTrading":{"tag":"盘后","latestPrice":1.7,"preClose":1.7,"latestTime":"15:43 EST","volume":22,"amount":37.76,"timestamp":1735073022261},"volumeRatio":0.6077676880531042},"requestUrl":"/m/hq/s/KAPA/wiki","defaultTab":"wiki","newsList":[{"id":"2483881986","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨18.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881986?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508279,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分,Calidi Biotherapeutics, Inc.股票出现异动,股价急速上涨18.53%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Calidi Biotherapeutics, Inc.公司简介:Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,致力于开发和商业化新型、强效和高效的基于干细胞的平台,用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311995be2313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311995be2313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAIR","CLDI","KAPA"],"gpt_icon":0},{"id":"2470239715","title":"Kairos Pharma(KAPA)盘前涨逾9% 拟与临床实验室合作开发配套生物标记物","url":"https://stock-news.laohu8.com/highlight/detail?id=2470239715","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470239715?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:57","pubTimestamp":1727258229,"startTime":"0","endTime":"0","summary":"金吾财讯 | Kairos Pharma(KAPA)盘前涨逾9%,截至发稿,报2.19美元。消息面上,Kairos Pharma计划与专门从事基因测序的临床实验室PreCheck Health Services合作,为Kairos针对前列腺癌和肺癌的ENV105疗法开发配套生物标记物。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"280248","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"2470233604","title":"Kairos Pharma盘前涨6% 公司计划与临床实验室合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2470233604","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470233604?lang=zh_cn&edition=full","pubTime":"2024-09-25 16:56","pubTimestamp":1727254583,"startTime":"0","endTime":"0","summary":"Kairos Pharma(KAPA.US)盘前涨5.97%报2.13美元。消息面上,Kairos Pharma计划与专门从事基因测序的临床实验室PreCheck Health Services合作,为Kairos针对前列腺癌和肺癌的ENV105疗法开发配套生物标记物。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"us","thumbnail":"http://n.sinaimg.cn/spider20240925/145/w529h416/20240925/a9d1-9418047a034d24197ae3aee1a6b935a9.jpg","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/spider20240925/145/w529h416/20240925/a9d1-9418047a034d24197ae3aee1a6b935a9.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-09-25/doc-incqkhfn5104516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["KAPA","BK4139","KAIR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kairospharma.com","stockEarnings":[{"period":"1week","weight":0.0241},{"period":"1month","weight":0.0625},{"period":"3month","weight":-0.086},{"period":"6month","weight":-0.575},{"period":"ytd","weight":-0.575}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kairos Pharma, Ltd.于2013年6月17日根据加利福尼亚州法律注册成立,名称为NanoGB13, Inc.,随后于2023年5月10日转换为特拉华州公司,名称为Kairos Pharma, Ltd.。该公司是一家临床阶段的生物制药公司,致力于为癌症患者提供治疗,旨在克服免疫抑制和耐药性方面的关键障碍。这些疗法包括用于治疗前列腺癌、肺癌、乳腺癌和胶质母细胞瘤的抗体和小分子。","exchange":"NASDAQ","name":"Kairos Pharma, Ltd.","nameEN":"Kairos Pharma, Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kairos Pharma, Ltd.,KAPA,Kairos Pharma, Ltd.股票,Kairos Pharma, Ltd.股票老虎,Kairos Pharma, Ltd.股票老虎国际,Kairos Pharma, Ltd.行情,Kairos Pharma, Ltd.股票行情,Kairos Pharma, Ltd.股价,Kairos Pharma, Ltd.股市,Kairos Pharma, Ltd.股票价格,Kairos Pharma, Ltd.股票交易,Kairos Pharma, Ltd.股票购买,Kairos Pharma, Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}